Literature DB >> 10526000

Posteroventral medial pallidotomy in Parkinson's disease.

A E Lang1, J Duff, J A Saint-Cyr, L Trepanier, R E Gross, W Lombardi, E Montgomery, W Hutchinson, A M Lozano.   

Abstract

There has been a resurgence in the use of functional neurosurgery for Parkinson's disease. An important factor that has played a role in this development is the recent understanding of the functional anatomy of the basal ganglia including a knowledge of the changes in the activities of neurons in the internal segment of the globus pallidus (Gpi) and the subthalamic nucleus (STN) in Parkinson's disease as well as the knowledge of the presence of segregated functional loops within the basal ganglia which include a sensory-motor loop that involves the posteromedial globus pallidus rather than the anterior GPi where earlier pallidotomy lesions had been made. Laitinen reintroduced the modern posteroventral medial pallidotomy (PVMP) in 1992. Since then it has become clear that this treatment has major effects on levodopa-induced dyskinesias and, unlike Vim thalamotomy, improves bradykinesia and rigidity as well as tremor. In this report, we review a number of topics related to PVMP including the clinical results of pallidotomy available in the literature as well as an update of our own 2 year follow-up data, studies evaluating factors that might predict the subsequent response to pallidotomy, the neuropsychological effects of the procedure, results of imaging studies including the correlation of clinical effects with lesion location, the question of bilateral pallidotomy and pallidotomy combined with deep brain stimulation and finally whether PVMP is effective in other parkinsonian disorders.

Entities:  

Mesh:

Year:  1999        PMID: 10526000     DOI: 10.1007/bf03161079

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  56 in total

1.  Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease.

Authors:  L V Laitinen; A T Bergenheim; M I Hariz
Journal:  J Neurosurg       Date:  1992-01       Impact factor: 5.115

2.  Microelectrode-guided posteroventral medial radiofrequency pallidotomy for Parkinson's disease.

Authors:  O Kopyov; D Jacques; C Duma; G Buckwalter; A Kopyov; A Lieberman; B Copcutt
Journal:  J Neurosurg       Date:  1997-07       Impact factor: 5.115

3.  Bimanual co-ordination in Parkinson's disease.

Authors:  K A Johnson; R Cunnington; J L Bradshaw; J G Phillips; R Iansek; M A Rogers
Journal:  Brain       Date:  1998-04       Impact factor: 13.501

4.  Posteroventral pallidotomy in a patient with parkinsonism caused by hypoxic encephalopathy.

Authors:  S Goto; N Kunitoku; N Soyama; K Yamada; A Okamura; M Yoshikawa; Y Hirata; E Uyama; Y Ushio
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

5.  Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease.

Authors:  P Limousin; J Greene; P Pollak; J Rothwell; A L Benabid; R Frackowiak
Journal:  Ann Neurol       Date:  1997-09       Impact factor: 10.422

6.  Globus pallidus stimulation activates the cortical motor system during alleviation of parkinsonian symptoms.

Authors:  K D Davis; E Taub; S Houle; A E Lang; J O Dostrovsky; R R Tasker; A M Lozano
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

7.  Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures.

Authors:  R Scott; R Gregory; N Hines; C Carroll; N Hyman; V Papanasstasiou; C Leather; J Rowe; P Silburn; T Aziz
Journal:  Brain       Date:  1998-04       Impact factor: 13.501

8.  Changes in the motor response to acute L-dopa challenge after unilateral microelectrode-guided posteroventral pallidotomy.

Authors:  M Merello; M I Nouzeilles; A Cammarotta; R Pikielny; R Leiguarda
Journal:  Clin Neuropharmacol       Date:  1998 Mar-Apr       Impact factor: 1.592

9.  Unilateral pallidotomy for Parkinson's disease promptly improves a wide range of voluntary activities--especially gait and trunk movements.

Authors:  C H Meyer
Journal:  Acta Neurochir Suppl       Date:  1997

10.  Pallidal stimulation for Parkinson's disease. Two targets?

Authors:  B Bejjani; P Damier; I Arnulf; A M Bonnet; M Vidailhet; D Dormont; B Pidoux; P Cornu; C Marsault; Y Agid
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

View more
  10 in total

Review 1.  Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases.

Authors:  Thomas J Feuerstein; Miriam Kammerer; Carl Hermann Lücking; Andreas Moser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

2.  Contribution of olivofloccular circuitry developmental defects to atypical gaze in autism.

Authors:  Jerzy Wegiel; Izabela Kuchna; Krzysztof Nowicki; Humi Imaki; Jarek Wegiel; Shuang Yong Ma; Efrain C Azmitia; Probal Banerjee; Michael Flory; Ira L Cohen; Eric London; W Ted Brown; Carolyn Komich Hare; Thomas Wisniewski
Journal:  Brain Res       Date:  2013-04-02       Impact factor: 3.252

3.  Parkinson's Disease: Surgical Options.

Authors:  Helen Bronte-Stewart
Journal:  Curr Treat Options Neurol       Date:  2003-03       Impact factor: 3.598

4.  Understanding Parkinson's disease and deep brain stimulation: Role of monkey models.

Authors:  Jerrold L Vitek; Luke A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

5.  Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats.

Authors:  P De Deurwaèrdere; M F Chesselet
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

Review 6.  Parkinson's disease: surgical options.

Authors:  J Hammerstad; P Hogarth
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

7.  The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates.

Authors:  M Lagière; S Navailles; L Mignon; A Roumegous; M-F Chesselet; P De Deurwaerdère
Journal:  Exp Brain Res       Date:  2013-03-28       Impact factor: 1.972

8.  Five-year follow-up of unilateral posteroventral pallidotomy in Parkinson's disease.

Authors:  Adriana M Strutt; Eugene C Lai; Joseph Jankovic; Farah Atassi; Elizabeth M Soety; Harvey S Levin; Robert G Grossman; Michele K York
Journal:  Surg Neurol       Date:  2008-06-02

9.  Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease.

Authors:  Samer D Tabbal; Mwiza Ushe; Jonathan W Mink; Fredy J Revilla; Angie R Wernle; Minna Hong; Morvarid Karimi; Joel S Perlmutter
Journal:  Exp Neurol       Date:  2008-02-14       Impact factor: 5.330

10.  "Getting physical": the management of neuropsychiatric disorders using novel physical treatments.

Authors:  Gin S Malhi; Colleen Loo; Catherine M Cahill; Jim Lagopoulos; Philip Mitchell; Perminder Sachdev
Journal:  Neuropsychiatr Dis Treat       Date:  2006-06       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.